News & Information

At Memorial Sloan Kettering, our leading edge research is constantly advancing what we know about cancer and new discoveries are improving care for patients here, and all over the world. In News and Information, you will find information about our groundbreaking work and the dedicated professionals who make it all happen.

For Journalists

Connect with us to reach MSK experts for media inquiries and for story ideas.

Learn more

Richard Nixon with Benno Schmidt (right) and Mr. Schmidt’s wife, Nancy, at the signing of the National Cancer Act
For more than 137 years, MSK has made historic contributions driving discovery and improving patient care. Take a look back at the progress we've made since the signing of the National Cancer Act in 1971.
In the News
View all articles
News Releases
Marie-Josée and Henry R. Kravis
The Marie-Josée Kravis Center for Cancer Immunobiology (CCI), made possible by a generous $40 million gift from Henry R. Kravis to honor the visionary leadership of his wife, Marie-Josée Kravis, will establish a strategic research infrastructure that will seamlessly unite MSK scientists and physicians to further accelerate immunotherapy treatments for people with cancer.
View all news releases

Media Coverage


Memorial Sloan Kettering Cancer Center has announced a $40 million gift from Henry R. Kravis to establish a hub for immunotherapy research. MSK’s Joan Massagué is quoted. 
Wednesday, May 31, 2023
Forbes list “America’s Best Employers for New Grads”. MSK is listed.
Tuesday, May 23, 2023
The Society of Memorial Sloan Kettering Cancer Center held its 16th annual Spring Ball at the elegant Pierre Hotel, generously hosted by De Beers. Each year, the Spring Ball hosts over 400 of MSK’s most high-profile supporters with the ongoing mission of funding patient care and research at the hospital. MSK’s Lisa DeAngelis and  T. Peter Kingham are quoted.
Monday, May 22, 2023

View all media coverage
News from the Lab
MSK News
Lymphoma patient Symantha Wilson
Symantha Wilson was crushed when chemotherapy quit fighting her lymphoma — and thrilled when immuno¬therapy beat back the cancer. But why doesn’t immunotherapy help more people? MSK researchers are finding answers.
View all MSK News
2022 Annual Report: It Takes MSK
Shanu Modi, MD, expert in developing new breast cancer treatments
MSK-led research could change the practice of medicine for millions of people whose breast cancer has spread. Research led by Dr. Shanu Modi has demonstrated that a targeted drug called trastuzumab deruxtecan blocks the protein HER2 even when its levels are low — the case for about 55% of people with breast cancer.
Scott Lowe, PhD, identified a precancerous sign in cells that is “sort of like the first wobble as the wheels start to fall off the wagon.”
The protein made by the p53 gene helps guard the body against cancer, in part by detecting and repairing damaged DNA. Over the 30 years since p53 was first discovered, it has remained a stubborn mystery, resisting efforts to tease apart exactly how the loss of the gene’s protection leads to the development of cancer. In August 2022, researchers in the Sloan Kettering Institute were able to provide some new answers that hint at new avenues for treatment.
View the full report
Cancer Straight Talk
Cancer Straight Talk brings together national experts and cancer patients to have straightforward, evidence-based conversations. Medical oncologist Diane Reidy-Lagunes hosts this series with the mission of educating and empowering patients to make the right decisions and live happier, healthier lives.